Vimta Labs Peer Comparison

NSE: VIMTALABS | BSE: 524394

₹496.45

₹-10.85 (-2.14%)

As on 06-Nov-2026IST

Market cap

₹2,218 Cr

Revenue (TTM)

₹429 Cr

P/E Ratio

27.6

P/B Ratio

4.5

Div. Yield

0.4 %

Edit

	Vimta Labs	Genesis IBRC India	Jeevan Scientific	Anthem Biosciences	Global Health
Market cap (₹ Cr)	2,218	763	162	51,539	37,300
Revenue (₹ Cr)	429	--	71	2,046	5,053
Net Profit (₹ Cr)	80.36	-0.86	5.14	613.98	613.08
Net Margin (%)	18.25	-2,391.67	7.16	27.72	11.89
RoE (%)	17.20	-3.56	5.85	19.97	15.63
Price to Earnings	27.61	--	46.57	83.94	60.32
Price-To-Book	4.51	4.00	2.47	15.71	8.63

Income Statement (₹ Cr)

	Vimta Labs	Genesis IBRC India	Jeevan Scientific	Anthem Biosciences	Global Health
Operating Revenue	407.29	--	61.54	2,124.33	4,410.27
Total Income	416.28	0.04	62.51	2,280.12	4,514.67
Total Expenditure	265.77	0.75	51.53	1,290.36	3,486.05
EBITDA	141.52	-0.75	10.01	833.97	924.22
Depreciation	43.77	--	6.64	134.07	222.54
EBIT	97.75	-0.75	3.36	699.90	701.68
Interest	1.17	0.00	2.23	7.06	90.05
Other Income	8.99	0.04	0.97	155.78	104.41
Exceptional Items	-1.62	--	--	-24.39	-1.02
Profit before Tax	103.95	-0.71	2.09	824.24	715.02
Provision for Tax	26.44	--	1.06	232.45	160.95
Profit after Tax	77.51	-0.71	1.03	591.79	554.07

	Vimta Labs	Genesis IBRC India	Jeevan Scientific	Anthem Biosciences	Global Health
Shareholder's Funds	456.87	40.07	71.72	3,042.52	3,961.57
Minority Interest	--	--	1.23	--	22.71
Non-Current Liabilities	33.55	--	13.74	33.74	1,277.95
Current Liabilities	65.52	5.24	19.89	529.71	627.13
Total Liabilities	562.23	45.31	106.59	3,633.29	5,905.00

	Vimta Labs	Genesis IBRC India	Jeevan Scientific	Anthem Biosciences	Global Health
Non-Current Assets	331.07	--	56.72	1,598.82	4,214.44
Current Assets	224.87	45.31	49.87	2,007.15	1,674.92
Total Assets	562.23	45.31	106.59	3,633.29	5,905.00
Total Debt*	3.33	0.00	17.16	51.07	631.08
Net Current Assets	159.35	40.07	29.98	1,477.43	1,047.79
Contingent Liabilities	1.95	--	--	90.20	100.01

	Vimta Labs	Genesis IBRC India	Jeevan Scientific	Anthem Biosciences	Global Health
Cash From Operating Activities	147.14	5.10	0.42	844.49	714.39
Cash Flow from Investing Activities	-129.67	--	-9.98	-701.62	-1,089.11
Cash from Financing Activities	-10.35	32.25	18.83	-40.00	271.85
Net Cash Inflow / Outflow	7.12	37.35	9.26	102.87	-102.87

	Vimta Labs	Genesis IBRC India	Jeevan Scientific	Anthem Biosciences	Global Health
ROCE (%)	24.81	-2.94	5.61	29.62	19.38
ROE (%)	18.87	-2.94	1.90	21.98	15.12
ROA (%)	15.25	-2.64	1.12	18.06	10.43
EBIT Margin (%)	36.95	--	17.84	46.59	23.32
Net Margin (%)	18.62	-2,042.00	1.65	25.95	12.27
Cash Profit Margin (%)	29.78	--	12.47	33.25	17.61

	Vimta Labs	Genesis IBRC India	Jeevan Scientific	Anthem Biosciences	Global Health
Revenue Growth (%)	18.40	--	31.37	15.17	19.44
EBIT Growth (%)	19.27	-120.39	33.56	30.79	6.57
Net Profit Growth (%)	16.11	-120.39	1,651.36	31.14	15.11
EPS Growth (%)	15.59	-105.86	658.14	30.53	15.54
Book Value Growth (%)	20.79	369.59	47.32	26.67	16.51

	Vimta Labs	Genesis IBRC India	Jeevan Scientific	Anthem Biosciences	Global Health
Price / Earnings	21.95	0.00	110.78	62.29	46.44
Price / Book Value	3.78	11.18	1.97	12.25	6.55
Dividend Yield (%)	0.53	0.00	0.00	0.30	0.05
EV/EBITDA	10.89	-574.48	12.31	37.02	24.64
Market Cap (₹ Cr)	1,701.05	--	127.48	36,865.25	25,841.07

	Vimta Labs	Genesis IBRC India	Jeevan Scientific	Anthem Biosciences	Global Health
Debt to Equity	0.01	0.00	0.27	0.02	0.16
Short term debt to equity ratio	--	--	0.05	0.00	--
Current Ratio	3.43	8.64	2.51	3.79	2.67
Quick Ratio	2.97	8.64	2.35	3.55	2.54
Interest Coverage	90.08	-7,146.00	1.94	117.83	8.94

	Vimta Labs	Genesis IBRC India	Jeevan Scientific	Anthem Biosciences	Global Health
Debtors to sales (%)	25.95	--	33.63	27.80	9.32
Asset Turnover	0.80	0.00	0.67	0.67	0.83
Receivable days	94.97	--	108.65	87.02	29.09
Inventory Days	24.65	--	13.78	38.87	6.05
Payable days	--	--	348.18	41.63	80.04
Cash Conversion Cycle	--	--	-225.76	84.26	-44.90

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.